Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.47)
# 3,320
Out of 4,876 analysts
50
Total ratings
54.84%
Success rate
-5.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Overweight | $136 → $147 | $133.67 | +9.97% | 5 | Apr 17, 2025 | |
| PODD Insulet | Maintains: Overweight | $305 → $322 | $309.83 | +3.93% | 4 | Feb 21, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $10.94 | +82.82% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $19.11 | +329.09% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $119.58 | +107.39% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $169.97 | +61.79% | 4 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $534.19 | -36.54% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.55 | +172.23% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $2.59 | +942.47% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $91.74 | +20.99% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $85.04 | +69.04% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $101.06 | -44.59% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $92.80 | -20.26% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $77.15 | -0.62% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $17.10 | +426.32% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $58.82 | - | 1 | Dec 12, 2019 |
Abbott Laboratories
Apr 17, 2025
Maintains: Overweight
Price Target: $136 → $147
Current: $133.67
Upside: +9.97%
Insulet
Feb 21, 2025
Maintains: Overweight
Price Target: $305 → $322
Current: $309.83
Upside: +3.93%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $10.94
Upside: +82.82%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $19.11
Upside: +329.09%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $119.58
Upside: +107.39%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $169.97
Upside: +61.79%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $534.19
Upside: -36.54%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.55
Upside: +172.23%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $2.59
Upside: +942.47%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $91.74
Upside: +20.99%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $85.04
Upside: +69.04%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $101.06
Upside: -44.59%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $92.80
Upside: -20.26%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $77.15
Upside: -0.62%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $17.10
Upside: +426.32%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $58.82
Upside: -